📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Devyser

1.1 - Company Overview

Devyser Logo

Devyser

Headquarter: Sweden
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of diagnostic kits for complex DNA testing in oncology, hereditary diseases, and transplantation, used to guide targeted cancer therapies and enable genetic testing. Sold in 60+ countries, offerings include NGS-based tests for thalassemia, cystic fibrosis, familial hypercholesterolemia, thrombophilia, HFE mutations, and Y-chromosome microdeletions linked to male infertility.

Products and services

  • Devyser AZF Extension: A molecular-grade diagnostic kit that detects microdeletions in the Y chromosome associated with male infertility, supporting precise identification of genetic abnormalities in complex DNA testing
  • Devyser Cystic Fibrosis NGS Test: An NGS-based diagnostic test that detects genetic mutations associated with cystic fibrosis, enabling identification of hereditary variants for targeted testing in complex DNA workflows
  • Devyser FH NGS: A laboratory-grade diagnostic kit utilizing next-generation sequencing to identify genetic mutations linked to familial hypercholesterolemia, supporting detection of inherited cholesterol disorder variants in clinical genetic testing

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Devyser

AmniSure Logo

AmniSure

HQ: United States Website
  • Description: Provider of the AmniSure ROM Test, a one-step, minimally invasive diagnostic strip that uses proprietary technology to detect tiny quantities of amniotic fluid in vaginal discharge. FDA-cleared for marketing, reimbursable under most U.S. state Medicaid plans, and approved in other markets; AmniSure International manufactures, markets, and distributes the test worldwide.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full AmniSure company profile →
Rubius Therapeutics Logo

Rubius Therapeutics

HQ: United States Website
  • Description: Provider of technology to grow, genetically engineer, and mature long-circulating Red-Cell Therapeutics.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Rubius Therapeutics company profile →
Ethris Logo

Ethris

HQ: Germany Website
  • Description: Provider of mRNA therapeutics and LNP delivery solutions focused on respiratory diseases and vaccines. Offers the SNIM RNA platform for stabilized non-immunogenic mRNA therapies and the SNaP LNP platform for targeted, inhalable delivery. Pipeline includes ETH47, ETH42, and ETH45 for respiratory indications. Provides in-house and partnered manufacturing with HPLC-free processes.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Ethris company profile →
Megazyme Logo

Megazyme

HQ: Ireland Website
  • Description: Provider of analytical enzymes, chromogenic substrates, high-purity polysaccharides and colourimetric oligosaccharides; assay kits including Rapid Integrated Total Dietary Fiber and Lactose Assay; and Food Safety Division dehydrated culture media and diagnostic tests for foodborne bacteria, natural toxins, genetic modifications and allergens, serving laboratories in food & beverages, biofuel, animal feed, wine & brewing, dairy and cereals.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Megazyme company profile →
seqWell Logo

seqWell

HQ: United States Website
  • Description: Provider of gene sequencing and laboratory services in the biotechnology field.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full seqWell company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Devyser

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Devyser

2.2 - Growth funds investing in similar companies to Devyser

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Devyser

4.2 - Public trading comparable groups for Devyser

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Devyser

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Devyser

What does Devyser do?

Devyser is a provider of diagnostic kits for complex DNA testing in oncology, hereditary diseases, and transplantation, used to guide targeted cancer therapies and enable genetic testing. Sold in 60+ countries, offerings include NGS-based tests for thalassemia, cystic fibrosis, familial hypercholesterolemia, thrombophilia, HFE mutations, and Y-chromosome microdeletions linked to male infertility.

Who are Devyser's competitors?

Devyser's competitors and similar companies include AmniSure, Rubius Therapeutics, Ethris, Megazyme, and seqWell.

Where is Devyser headquartered?

Devyser is headquartered in Sweden.

How many employees does Devyser have?

Devyser has 1,000 employees 🔒.

When was Devyser founded?

Devyser was founded in 2010 🔒.

What sector and industry vertical is Devyser in?

Devyser is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Devyser

Who are the top strategic acquirers in Devyser's sector and industry

Top strategic M&A buyers and acquirers in Devyser's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Devyser?

Top strategic M&A buyers groups and sectors for Devyser include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Devyser's sector and industry vertical

Which are the top PE firms investing in Devyser's sector and industry vertical?

Top PE firms investing in Devyser's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Devyser's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Devyser's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Devyser's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Devyser include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Devyser's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Devyser?

The key public trading comparables and valuation benchmarks for Devyser include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Devyser for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Devyser with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Devyser's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Devyser with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Devyser's' sector and industry vertical?

Access recent funding rounds and capital raises in Devyser's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Devyser